ALABISO, Oscar
 Distribuzione geografica
Continente #
EU - Europa 2.283
NA - Nord America 1.941
AS - Asia 299
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 3
OC - Oceania 1
Totale 4.534
Nazione #
US - Stati Uniti d'America 1.931
IE - Irlanda 732
DE - Germania 391
SE - Svezia 348
UA - Ucraina 283
IT - Italia 193
FI - Finlandia 182
CN - Cina 152
FR - Francia 107
HK - Hong Kong 82
IN - India 29
GB - Regno Unito 23
IR - Iran 19
BE - Belgio 14
VN - Vietnam 12
CA - Canada 10
EU - Europa 7
TR - Turchia 4
BR - Brasile 3
NL - Olanda 2
PT - Portogallo 2
RU - Federazione Russa 2
AU - Australia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
GR - Grecia 1
ID - Indonesia 1
RO - Romania 1
Totale 4.534
Città #
Dublin 732
Jacksonville 527
Dearborn 277
Wilmington 157
Chandler 136
San Mateo 93
Lawrence 92
Princeton 92
Ann Arbor 90
Hong Kong 82
Beijing 69
Andover 65
Bremen 48
Ashburn 45
Piemonte 42
Grafing 29
Torino 26
Nanjing 16
Boardman 15
Brussels 14
Dong Ket 12
Houston 12
Norwalk 12
Hefei 11
Woodbridge 11
Kunming 10
Rome 10
Helsinki 9
Philadelphia 8
West Jordan 8
Zanjan 8
Augusta 7
Leawood 7
Monmouth Junction 7
Toronto 7
Düsseldorf 6
Guangzhou 6
Turin 6
Fuzhou 5
Milan 5
Ardabil 4
Jinan 4
Nanchang 4
New York 4
Shenyang 4
Baotou 3
Faenza 3
Genova 3
Marsciano 3
Taurisano 3
Antalya 2
Bari 2
Brescia 2
Dallas 2
Erchie 2
Ferentino 2
Galliate Lombardo 2
Hebei 2
Jinhua 2
Kocaeli 2
Montréal 2
Sacramento 2
Setúbal 2
Treviso 2
Adelaide 1
Alba 1
Americana 1
Arona 1
Buffalo 1
Cambridge 1
Cesena 1
Cetraro 1
Chengdu 1
Des Moines 1
Downers Grove 1
Eindhoven 1
Fairfield 1
Florence 1
Giugliano In Campania 1
Henderson 1
Horia 1
Kilburn 1
Kish 1
Kyiv 1
Leipzig 1
Marburg 1
Nanning 1
Napoli 1
Novara 1
Nuremberg 1
Pavia 1
Quzhou 1
Redmond 1
Redwood City 1
San Diego 1
San Giuliano Milanese 1
Santa Clara 1
Seattle 1
Shaoxing 1
Simi Valley 1
Totale 2.913
Nome #
Case report : Herceptin e carcinoma mammario 95
Resveratrol inhibits IL-6-induced ovarian cancer cell migration through epigenetic up-regulation of autophagy 88
Autophagy and thyroid carcinogenesis: genetic and epigenetic links 83
Integrins in T Cell Physiology 77
Economic burden of patients affected by non-small cell lung cancer (NSCLC): the LIFE study 76
First-Line Bevacizumab-Based Therapy in Advanced Non-Squamous Non-Small-Cell Lung Cancer: Analysis of the Italian Patients Enrolled in the SAiL Study 75
PTEN deficiency and mutant p53 confer glucose-addiction to thyroid cancer cells: impact of glucose depletion on cell proliferation, cell survival, autophagy and cell migration. 75
Carcinoma sarcomatoide della prostata: caso clinico 74
Safety and activity of docetaxel and trastuzumab in HER2 overexpressing metastatic breast cancer. a pilot phase II study 73
Case report : Metastatic melanoma 65
Limits of aortic stop flow infusion chemotherapy in the treatment of advanced cancer 64
Experience of integration among different lists in oncological equipe : doctors, nurses , psychologists 64
Ependimoma anaplastico della regione dorso lombare in adulto: caso clinico 63
Combined regional and systemic chemotherapy by a mini-invasive approach for the treatment of colorectal liver metastases 62
Mutation analysis of the EGFR gene and downstream signalling pathway in histologic samples of malignant pleural mesothelioma. 61
Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymfoproliferative disorders 61
PTEN regulates plasma membrane expression of glucose transporter 1 and glucose uptake in thyroid cancer cells. 60
FULD Combination Given as Hepatic Artery Infusion (HAI) in Colon-Rectal Liver Metastases (CLM) by a Percutaneously Placed Port-a-Cath (PAC) in Elderly or Unfit Patients (EUP) 57
TCFW:5FUpvi in combination with weekly docetaxel and CDDP in advanced gastric cancer, a phase I-II study: the dose finding step."Rete Oncologica Piemontese" 57
The role of lung metastasis resection in improving outcome of colorectal cancer patients: results from a large retrospective study 56
Mutation analysis of KRAS in primary colorectal cancer and matched metastases by means of highly sensitivity molecular assay. 56
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma 56
Disparity in the 'time to patient access' to new anti-cancer drugs in Italian regions. Results of a survey conducted by the Italian Society of Medical Oncology (AIOM) 54
Venous thromboembolism in lung cancer: retrospective analysis of data in outpatients treated at oncology department of Novara 54
Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy: a phase II ITMO study. 54
Singola localizzazione paravertebrale in seminoma testicolare: un caso clinico 53
Docetaxel plus androgen deprivation withdrawal may restore sensitivity to luteinizing hormone-releasing hormone analog therapy in castration-resistant prostate cancer patients 53
Association between ultrarapid CYP2D6 polymorphisms and adverse drug reactions among women with breast cancer treated with tamoxifen 52
Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study 52
Phase I trial of tomudex ( TOM ) + protracted – venous- infusion 5-fluorouracil (PVI-5FU ) in advanced ileal and colorectal cancer 51
CARCINOMA DEL COLON METASTATICO: CASE REPORT 51
The incidence of venous thromboembolism (VTE) in metastatic colorectal cancer (mCRC) patients 51
Circannual variation of efficacy outcomes in patients with newly diagnosedmetastatic colorectal cancer and treated with first-line chemotherapy 51
Risposta completa prolungata e terapia con sunitinib in paziente affetto da carcinoma a cellule renali metastatico 51
RMN DWIBS (Diffusion Weighet Body Imaging With Background Body Signal Suppression) WHOLE BODY in oncologia: studio osservazionale risultati preliminary 50
Venous thromboembolism in non-small cell lung cancer patients: retrospective analysis of cases treated at the Oncology Day Hospital of Novara, Italy 50
Differences in the availability of new anti-cancer drugs for Italian patients treated in different regions. Results of analysis conducted by the Italian Society Of Medical Oncology 50
Docetaxel and Oxaliplatin in weekly administration in solid tumors: dose finding study 50
Preliminary Results of a Phase II Study with Gemcitabine and Continuous Infusion 5FU in Patients with Advanced or Metastatic Pancreatic Cancer 49
Carcinoma del colon metastatico: caso clinico. Bevacizumab e Capecitabina nella pratica clinica. Current therapeutics. Adis Milano 2006 49
Comparison of the Tolerability Profile of Controlled-Release Oral Morphine and Oxycodone for Cancer Pain Treatment. An Open-Label Randomized Controlled Trial 49
Pelvic Intra-Arterial Infusion via Percutaneous Arterial Port for Locoregional Chemotherapy of Cancer Relapses 49
Inguinal sentinel node in anal neoplasms 48
Expression and Clinical Significance of the Autophagy Proteins BECLIN 1 and LC3 in Ovarian Cancer 48
Tumore misto mülleriano dell’endometrio: case report 47
FISH in triple-negative breast cancer: a possible strategy for the future? 47
Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network 47
Hepatic arterial infusion chemotherapy for Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma 47
Final report of a phase II trial of Gemcitabine (GEM) with 5FU continous infusion (CI) in the treatment of advanced pancreatic cancer (APC) 46
Localizzazione gengivale metastatica in paziente affetta da carcinoma colorettale avanzato: caso clinico 46
Gemcitabine in vitro activity on hepatocellular carcinoma: basic pharmacological parameters and drug combinations 46
Neoplasia a primitività ignota: case report 46
Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: Results from the Italian observational "SUN" (Survey on the lUng cancer maNagement) study. Lung Cancer 46
High serum levels of Transforming Growth Factor-beta1, Interleukin-10 and Vascular Endothelial Growth Factor in pancreatic adenocarcinoma patients 45
A phase II study of three-weekly docetaxel and weekly trastuzumab in HER2-overexpressing advanced breast cancer (ABC) 44
Migrazione epatica di cellule A-LAK autologhe espanse e marcate con 111Indio ex-vivo in pazienti affetti da metastasi epatiche di carcinoma del grosso intestino 44
Autophagy inhibition enhances anthocyanin-induced apoptosis in hepatocellular carcinoma 44
p27Kip1 is inactivated in human colorectal cancer by cytoplasmic localization associated with activation of Akt/PKB 44
Seminoma del testicolo: localizzazione paravertebrale di malattia: caso clinico 42
Palliative treatment for elderly patients with colon cancer in ten Italian medical oncology units 42
Side effects associated with ultrarapid cytochrome P450 2D6 genotype among women with early stage breast cancer treated with tamoxifen 41
Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma 41
Impact of use of oral anticancer drugs on activity of Italian oncology practices: results of a survey conducted by the Italian Society of Medical Oncology (AIOM) 41
Observational study on quality of life, safety, and effectiveness of first-line cetuximab plus chemotherapy in KRAS wild-type metastatic colorectal cancer patients: the ObservEr Study 41
Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM) 41
Tolerability and compliance to chemotherapy in psychiatric patients with cancer 40
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE). 40
Feasibility of fludarabine based treatment for lymphoproliferative disorders in patients over eighty years old 39
Interim Results of a Phase II Trial of Raltitrexed (RAL) + Protracted-Venous-Infusion-5-Fluorouracil (PVI-5-FU) in Advanced Colorectal Cancer 39
Tossicita’ da trattamento con Bevacizumab: l’esperienza della S.C.D.U. Oncologia medica di Novara 39
Riflessione sugli aspetti psicosociali in oncologia 39
Topotecan (T) and ifosfamide (I) as salvage treatment in advanced ovarian cancer 38
Intra-arterial continuous infusion for treatment of pancreatic and biliary tract cancer 38
Efficacy and Safety of RAD001 as Second Line Therapy in Biliary Tract Cancer (BTC) Patients (pts) – a Phase II I.T.M.O. (Italian Trials in Medical Oncology) Group Study 38
Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer 38
Involvement of autophagy in ovarian cancer: a working hypothesis 37
The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients 37
Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients 36
Whole-body diffusion-weighted magnetic resonance imaging in the staging of oncological patients: comparison with positron emission tomography computed tomography (PET-CT) in a pilot study 36
Impact of hemoglobin levels in psychiatric patients with cancer 35
The CAP-CR study: direct medical costs in Italian metastatic colorectal cancer patients on first-line infusional 5-fluorouracil or oral capecitabine 35
Secondary neoplasms: our experience 34
Variation in gynecological oncology follow-up practice: attributable to cancer centers or to patient characteristics? A Piedmont Regional Oncology Network Study 34
null 34
Safety and activity of docetaxel and trastuzumab in HER2 overexpressing metastatic breast cancer: a pilot phase II study 33
Preliminary results of phase II trial with combination of gemcitabine and oxaliplatin in elderly patients with advanced NSCLC 33
Tolerability and compliance to chemotherapy in neuropsychiatric patients 33
Two cases of secondary soft tissue sarcomas after radiotherapy and radiochemiotherapy 33
Prophylactic effect of reduced glutathione (GSH) on oxaliplatin chronic cumulative neurotoxicity (CCN) 30
Port in oncology practice: 3-monthly locking with normal saline for catheter maintenance, a preliminary report 30
Stage IV gastric cancer and FOLFOX 6. Case report 29
The role of hemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer (ACC) patients 29
Pericardial metastases in a long-surviving patient with sigmoid carcinoma 29
Prospective study on prognostic significance of DNA ploidy and Ki-67 expression in colorectal cancer 29
Totale 4.559
Categoria #
all - tutte 20.117
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.117


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201914 0 0 0 0 0 0 0 0 0 0 10 4
2019/20201.035 15 5 110 2 193 167 205 49 113 62 109 5
2020/2021629 99 0 98 2 64 15 98 7 93 29 103 21
2021/2022676 26 8 138 57 35 1 91 13 40 17 134 116
2022/20231.360 107 37 62 36 115 123 37 73 711 3 36 20
2023/2024285 27 19 40 4 81 2 88 4 4 10 6 0
Totale 4.559